XENE ▼ -3.1% - Xenon Pharmaceuticals Inc. $XENE - Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Xenon Pharmaceuticals shares fell 3.1% following the company's announcement of inducement grants under Nasdaq listing rules. The announcement typically involves stock option or equity grants to employees, which can dilute existing shareholders' ownership stakes. While inducement grants are a standard HR practice for new hires, the market's negative reaction suggests investors may be concerned about the dilutive impact or other implications of the equity issuance. 28-AUG-2026 04:01 PM ET